Circulating pegfr is a candidate response biomarker of cetuximab therapy in colorectal cancer

Theodora Katsila, Mercèe Juliachs, Josep Gregori, Teresa Macarulla, Laura Villarreal, Alberto Bardelli, Chris Torrance, Elena Elez, Josep Tabernero, Josep Villanueva

Research output: Contribution to journalArticleResearchpeer-review

17 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Circulating pegfr is a candidate response biomarker of cetuximab therapy in colorectal cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences